当前位置: 首页 > 期刊 > 《中国当代医药》 > 2012年第5期
编号:12192123
黄芪提高乙型肝炎患者自身免疫作用有效性的临床观察
http://www.100md.com 2012年2月15日 《中国当代医药》 2012年第5期
     [摘要] 目的 临床证实黄芪提高乙型肝炎患者自身免疫的作用。 方法 观察乙型肝炎患者用黄芪治疗前后主要病毒学指标的变化。 结果 黄芪能够抑制HBsAg、HBeAg的分泌,使乙肝血清标志物HBsAg(+)、HBeAg(+)、HBcAb(+)转换为HBsAg(+)、HBeAb(+)、HBcAb(+),有效率达70%,实现免疫调节功能。 结论 黄芪是最常用的中药之一,对常规治疗数疗程仍无明显改善的乙型肝炎患者有良好的治疗效果,且价廉易得,值得推广。

    [关键词] 黄芪;乙型肝炎;免疫;临床观察

    [中图分类号] R287 [文献标识码] A [文章编号] 1674-4721(2012)02(b)-0112-02

    Clinical observation of Astragalus to improve autoimmune function of patients with hepatitis B

    WANG Ruoqi NI Bei

    The General Hospital of Xuzhou Mining Group in Jiangsu Province, Xuzhou 221000, China

    [Abstract] Objective To prove the autoimmune function of patients with hepatitis B of Astragalus. Methods Main virological indicators of patients with hepatitis B were observed before and after treatment with Astragalus. Results Astragalus could inhibit the secretion of HbsAg and HBeAg, to make the hepatitis B serum markers of HBsAg(+), HBeAg(+) and HBcAb(+) converted to HBsAg(+), HBeAb(+)and HBcAb(+), and achieved the immune function. The general efficiency was about 70 percent. Conclusion Astragalus is most commonly used for patients with no significant improvement treated by conventional methods, and has good therapeutic effect. Astragalus is also cheap and easy to get, which is worthy of promotion. ......

您现在查看是摘要页,全文长 5865 字符